Cardiodiabetes Update
A Textbook of Cardiology


Language: Anglais
Cover of the book Cardiodiabetes Update

Subjects for Cardiodiabetes Update

Approximative price 266.94 €

In Print (Delivery period: 14 days).

Add to cartAdd to cart
Publication date:
972 p. · 21.5x27.9 cm · Hardback
Cardiodiabetes refers to heart disease that develops in people who have diabetes. Compared with people who don't have diabetes, people who have diabetes are at higher risk of heart disease, have additional causes of heart disease, may develop heart disease at a younger age, and may have more severe heart disease.

With nearly 1000 pages, this manual is a complete guide to the diagnosis and management of cardiodiabetes. Divided into nine sections, each chapter addresses a separate and distinct issue of clinical relevance. The book provides an insight into clinical spectrum, diagnostic methodology, management strategies, nutraceutical and obesity care, arrhythmia management, coronary intervention, cardiac surgery, rehabilitation, and future directions in cardiodiabetes care.

Additionally, the text features discussion on strategies to reduce the growing prevalence of diabetes, and the current pathophysiological understanding of cardiovascular comorbidities in patients with diabetes. More than 500 clinical photographs, illustrations, tables and boxes further enhance the comprehensive text


  • Clinical Spectrum of Cardiodiabetes
  • Risk Factors for Cardiodiabetes
  • Cardiodiabetes in Children
  • New Genes for Type 2 Diabetes: Indian Scenario
  • Stress and Cardiodiabetes
  • Hypothyroidism and Cardiodiabetes
  • Cardiodiabetes and Insulin Resistance in Obesity: Clinical Relevance
  • Anemia and Cardiodiabetes: Management Strategies
  • Endothelial Dysfunction in Atrial Fibrillation with Type 2 DM
  • ACS, Cardiodiabetes, and Women
  • Coronary Artery Disease in Diabetes: How Different is It from Nondiabetics?
  • Cardiodiabetes and Heart Failure in the Elderly
  • Prognosis of Heart Failure in Diabetes: Newer Perspectives
  • Cardiodiabetes Management and STEMI: Prognostication
  • Small Vessel CAD in Cardiodiabetes
  • Cardiodiabetes and Deep Venous Thrombosis
  • Pregnancy and Cardiodiabetes
  • Cardiodiabetes and Autonomic Insufficiency
  • Cardiodiabetes and Pulmonary Embolism: Is the Outcome Different?
  • Cardiodiabetes and Cutaneous Manifestations
  • Benidipine for Hypertension in Chronic Kidney Disease with Cardiodiabetes
  • Cardiorenal Diabetes: Triple Jeopardy
  • Contrast-induced Acute Kidney Injury
  • Cardiodiabetes and Hypertension: Double Jeopardy
  • Cardiodiabetes and Obstructive Sleep Apnea
  • Cardiodiabetes and Mind-Heart Connection
  • Aortic Aneurysm Surgery in Cardiodiabetes: Is the Outcome Different?
  • Cardiodiabetes and Syncope
  • Cardiodiabetes and Sexual Dysfunction
  • Cardiodiabetes and Erectile Dysfunction
  • Endothelial Cell Dysfunction in DM, HT and CAD, and Its Pathophysiology



  • Current Status of Diabetic Cardiomyopathy
  • Insulin Therapy and Cardiodiabetes
  • Echo-guided CRT in Cardiodiabetes
  • Echocardiography in Diabetes
  • Echo/Doppler Assessment of Increased Left-sided Filling Pressures and Diastolic Heart Failure in Patients with Normal Systolic Function in Cardiodiabetes
  • 3D Echo and Cardiodiabetes
  • Emergency Echocardiography in Cardiodiabetes
  • Diabetic Cardiomyopathy: Studies on Global Longitudinal Strain in Asymptomatic Diabetic Subjects
  • Strain and Strain Rate Imaging in Cardiodiabetes
  • Dobutamine Stress Echo for Coronary Artery Disease Evaluation in Diabetics
  • Noninvasive Cardiovascular Imaging for Risk Assessment in Asymptomatic Diabetic Patients
  • Value of Ankle–Brachial Index in Cardiodiabetes
  • Computed Tomography Evaluation of Abdominal Arterial Wall Calcification in Patients with Type 2 Diabetes Mellitus
  • Cardiac MRI: A Promise, Hope or Hype in Cardiodiabetes
  • CT for CVD Evaluation in Cardiodiabetes
  • Recent Advances in Nuclear Cardiology and Cardiodiabetes
  • Blood Pressure Variability in Cardiodiabetes
  • Central Aortic Blood Pressure Evaluation for Hypertension in Cardiodiabetics
  • Telemedicine in Diabetes Management
  • HbA1c: Clinical Relevance in Cardiodiabetes
  • Emerging Role of Cardiac Troponin in Cardiodiabetes



  • Role of Yoga in Cardiodiabetes
  • Metabolic Effects of Antihypertensive Drugs
  • Potential Role of Rosuvastatin in Cardiodiabetes
  • Diabetic Hypertriglyceridemia: Management Strategies
  • High-density Lipoprotein in Cardiodiabetes
  • Glucose-lowering Strategies and Cardiovascular Outcomes
  • Improving CV Outcomes in Diabetes with New Antidiabetic Medications: A New Era has Begun
  • Positioning of Once Weekly GLP–1- based Therapies for Whom and When?
  • DPP-IV Inhibitors beyond Glycemic Efficacy
  • Insulin Therapy and Cardiodiabetes in Critical Care
  • Lixisenatide: A Cardiodiabetes Perspective
  • SGLT2-i Agents and Cardiovascular Diabetology
  • SGLT2-i for the Reduction of Cardiovascular Events in High-risk Patients with Diabetes Mellitus
  • Diabetes and Heart Failure: New Data on the Role of SGLT 2 Inhibitors— A Change of Concept?
  • Bisoprolol: Is It Superior in Cardiodiabetes?
  • Bisoprolol: A Choice of Beta Blocker in Hypertension and ACS in Cardiodiabetes
  • Bisoprolol in Heart Failure in Cardiodiabetes
  • Nebivolol for Hypertension in Cardiodiabetes
  • ARB for Hypertension in Cardiodiabetes
  • CKD and Hypertension: Is Benidipine Beneficial?
  • Azilsartan: Promise and Power for Hypertension in Cardiodiabetes
  • Benidipine for Hypertension in Cardiodiabetes
  • Azilsartan: A Molecule of First Choice for Hypertension in Cardiodiabetes
  • Superiority of Telmisartan: ARB, the First Choice in Cardiodiabetes
  • ARNI in Heart Failure with Cardiodiabetes: The Way Forward
  • Indapamide versus Hydrochlorothiazide versus Chlorthalidone in Cardiodiabetes
  • Polypill for Cardiovascular Protection in Diabetes
  • Clopidogrel in Patients of Diabetes with Acute Coronary Syndrome
  • Acute Coronary Syndrome in Cardiodiabetes: Is It Different?
  • Newer Drugs in Heart Failure and Changes in Our Clinical Approach
  • Role of Oral Anticoagulants in Atrial Fibrillation with Cardiodiabetes
  • Low-molecular-weight Heparin in Acute Coronary Syndrome in Cardiodiabetes
  • Myocardial Bridging
  • Benidipine for Hypertension in STEMI with Cardiodiabetes
  • Thrombolytic Therapy of Choice in STEMI with Cardiodiabetes
  • Tenecteplase and ST-elevation Myocardial Infarction with Cardiodiabetes
  • Cardiodiabetes and Stroke
  • Hemorrhagic Stroke and Cardiodiabetes
  • Prognostication of STEMI in Cardiodiabetes
  • Management of Hypertension in Diabetes: Special Consideration
  • Benidipine: A New Calcium Channel Blocker for Management of Hypertension and Angina in Cardiodiabetes
  • Azilsartan for Hypertension Management in Cardiodiabetes
  • Need for Registry of Cardiodiabetes in India
  • Nonpharmacological Management of Cardiodiabetes
  • Maternal Diabetes Mellitus and Fetal Cardiac Malformations: Antenatal and Postnatal Management and Outcome
  • Role of Enhanced External Counterpulsation: Future Perspectives



  • Role of Vitamin D as Cardioprotection Strategy: Hope or Hype?
  • Omega-3 Fatty Acids and Cardiovascular Disease
  • Role of Red Yeast Rice and Phytosterols in Dyslipidemia
  • Meal Replacement Therapy for Obesity Care in Cardiodiabetes
  • Ideal Edible Oil in Cardiodiabetes
  • Cardiodiabetic Diet



  • Cardiodiabetes and Heart Rate Variability
  • Natural History of Atrial Fibrillation in Cardiodiabetes: Is it Different?
  • Atrial Fibrillation: Management Strategies in Cardiodiabetics
  • Ventricular Tachycardia in Heart Failure with Cardiodiabetes
  • Sudden Cardiac Death in Patients with Diabetes Mellitus: Prevalence, Predictors and Preventive Strategies
  • Prevention of Sudden Cardiac Death in Cardiodiabetes
  • Pacing in Cardiodiabetes
  • Radiofrequency Ablation in Atrial Fibrillation in Cardiodiabetes
  • LA Appendage Closure for AF in Cardiodiabetes: Is the Outcome Different?
  • AICD after Cardiac Arrest in Cardiodiabetes



  • Coronary Interventions in Cardiodiabetes Prognostication
  • Primary PCI for STEMI in Cardiodiabetes: What is the Outcome?
  • Optimizing Results of Percutaneous Coronary Intervention in Multivessel Disease with Diabetes
  • STEMI Management in Diabetes Mellitus: Is it Different?
  • CTO with STEMI in Cardiodiabetes: Is the Outcome Different?
  • Coronary Intervention in Venous Grafts in Diabetes
  • Cardiodiabetes and Peripheral Vascular Interventions
  • Cardiodiabetes and Vasculopathy
  • Cardiodiabetes and Carotid Artery Interventions
  • Coronary Revascularization in Diabetics
  • Endovascular Intervention in Stroke in Cardiodiabetes: New Frontiers



  • Coronary Artery Bypass Grafting in Cardiodiabetes
  • Cardiac Surgery and Diabetes
  • ECMO for Cardiodiabetes



  • Cardiac Rehabilitation in Cardiodiabetes
  • Post-STEMI Intervention: Rehabilitation in Cardiodiabetes
  • Role of Nurses in a Structured Manner for Cardiac Rehabilitation in Cardiodiabetes



  • Type 2 Diabetes and Coronary Artery Bypass Grafting: Relation and Outcomes
Cardiologists, Diabetologist

HK Chopra
Senior Consultant Cardiologist, Moolchand Medicity, New Delhi, India